(Q38032163)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864730%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

title

Risks, benefits, and therapeutic potential of hematopoietic stem cell transplantation for autoimmune diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864730%20AND%20SRC:MED&resulttype=core&format=json

stem cell transplantation

10 February 2020

main subject

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864730%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

Carlos Eduardo Barra Couri

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864730%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Maria Carolina de Oliveira

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864730%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

publication date

1 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864730%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

published in

Current diabetes report

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864730%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864730%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864730%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

604-611

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864730%20AND%20SRC:MED&resulttype=core&format=json

Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus

10 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Cell surface biomarkers of embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Perinatal sources of mesenchymal stem cells: Wharton's jelly, amnion and chorion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Human stem cell research and regenerative medicine--present and future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Sources of stem cells for regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Milestones in umbilical cord blood transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Executive summary: Standards of medical care in diabetes--2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Human type 1 diabetes and the insulin gene: principles of mapping polygenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Type 1 diabetes: virus infection or autoimmune disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Type 1 diabetes: recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Genetics, pathogenesis and clinical interventions in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

A choice of death--the signal-transduction of immune-mediated beta-cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Isolation of a candidate human hematopoietic stem-cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Stem cell transplantation for autoimmune disorders. Coincidental autoimmune disease in patients transplanted for conventional indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Autologous haemopoietic stem cell transplantation in a patient with severe pulmonary hypertension complicating connective tissue disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Haemopoietic stem cell transplantation for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Autologous hematopoietic stem cell transplantation for autoimmune disease--is it now ready for prime time?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Identification of a human recent thymic emigrant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Non-myeloablative stem cell transplantation for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Up-regulation of fas and fasL pro-apoptotic genes expression in type 1 diabetes patients after autologous haematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Stem cell-based therapies and immunomodulatory approaches in newly diagnosed type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Immunological applications of stem cells in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Autologous hematopoietic stem cell transplantation modulates immunocompetent cells and improves β-cell function in Chinese patients with new onset of type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Failure to preserve beta-cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new- onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Ovarian recovery after stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Autoimmune thyroid dysfunction after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Autoimmune polyendocrine syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS11892-012-0309-0

21 January 2018

12 December 2020

Alleviation of exogenous insulin requirement in type 1 diabetes mellitus after immunoablation and transplantation of autologous hematopoietic stem cells

1 reference

12 December 2020

High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases

1 reference

12 December 2020

Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation

1 reference

12 December 2020

Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes type I

1 reference

12 December 2020

Testicular function in patients with type 1 diabetes treated with high-dose CY and autologous hematopoietic SCT

1 reference

12 December 2020

Secondary prevention of type 1 diabetes mellitus: stopping immune destruction and promoting beta-cell regeneration

1 reference

12 December 2020

Use of microarray analysis to unveil transcription factor and gene networks contributing to Beta cell dysfunction and apoptosis

1 reference

12 December 2020

Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation.

1 reference

12 December 2020

Autoimmune type 1 diabetes: resolved and unresolved issues

1 reference

12 December 2020

Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function

1 reference

12 December 2020

Hematopoietic stem cell transplantation prevents diabetes in NOD mice but does not contribute to significant islet cell regeneration once disease is established

1 reference

12 December 2020

Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

1 reference

12 December 2020

Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

New opportunities for the treatment of severe autoimmune diseases: bone marrow transplantation

1 reference

12 December 2020

Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation.

1 reference

12 December 2020

Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation

1 reference

12 December 2020

10.1007/S11892-012-0309-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864730%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

10 February 2020

1007136938

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864730%20AND%20SRC:MED&resulttype=core&format=json